首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PHARMACEUTICAL PREPARATION FOR CANCER TREATMENT CONTAINING SAME COMPOSITION AS ACTE INGREDIENT

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PHARMACEUTICAL PREPARATION FOR CANCER TREATMENT CONTAINING SAME COMPOSITION AS ACTE INGREDIENT

机译:包含相同成分作为乙酸成分的癌症治疗药物组合物和癌症治疗药物制剂

摘要

It is an object of the present invention to provide a novel chemotherapeutic drug which is highly effective against solid cancer, has no side effects such as a chemotherapeutic agent, and is resistant to resistance. A stem cell preparation step of introducing four kinds of genes into a mesenchymal stem cell obtained from the dimensions of a mammal and transforming the mesenchymal stem cell into a non-mesenchymal stem cell; , And a condition medium preparation process for preparing a condition culture, wherein the condition is prepared by culturing under the same conditions except that the oxygen concentration is 20% (IGF-1) and a vascular endothelial cell growth factor (VEGF) at a dose of 1.5 times or more as compared with the culture medium.
机译:本发明的目的是提供一种新型的化学治疗药物,其对实体癌高度有效,并且没有诸如化学治疗剂的副作用,并且具有抗性。干细胞制备步骤,将四种基因导入哺乳动物尺寸的间充质干细胞中,并将间充质干细胞转化为非间充质干细胞。 ,以及用于制备条件培养物的条件培养基制备方法,其中通过在相同条件下培养来制备条件,不同之处在于氧剂量为20%(IGF-1)和一定剂量的血管内皮细胞生长因子(VEGF)是培养基的1.5倍以上。

著录项

  • 公开/公告号KR20160120726A

    专利类型

  • 公开/公告日2016-10-18

    原文格式PDF

  • 申请/专利权人 가부시키가이샤 쿠오리맨 앤 코.;

    申请/专利号KR20167021909

  • 发明设计人 우에다 미노루;

    申请日2015-01-23

  • 分类号A61K35/12;A61K38/18;A61K38/30;C12N5/074;

  • 国家 KR

  • 入库时间 2022-08-21 14:13:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号